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Abstract
Background
Randomised controlled trials (RCTs) are essential for evidence-based medicine and
increasingly rely on front-line clinicians to recruit eligible patients. Clinicians’ difficulties with
negotiating equipoise is assumed to undermine recruitment, although these issues have
not yet been empirically investigated in the context of observable events. We aimed to
investigate how clinicians conveyed equipoise during RCT recruitment appointments
across six RCTs, with a view to (i) identifying practices that supported or hindered equi-
poise communication and (ii) exploring how clinicians’ reported intentions compared with
their actual practices.
Methods and Findings
Six pragmatic UK-based RCTs were purposefully selected to include several clinical spe-
cialties (e.g., oncology, surgery) and types of treatment comparison. The RCTs were all
based in secondary-care hospitals (n = 16) around the UK. Clinicians recruiting to the RCTs
were interviewed (n = 23) to understand their individual sense of equipoise about the RCT
treatments and their intentions for communicating equipoise to patients. Appointments in
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which these clinicians presented the RCT to trial-eligible patients were audio-recorded (n =
105). The appointments were analysed using thematic and content analysis approaches to
identify practices that supported or challenged equipoise communication. A sample of
appointments was independently coded by three researchers to optimise reliability in
reported findings. Clinicians and patients provided full written consent to be interviewed
and have appointments audio-recorded.
Interviews revealed that clinicians’ sense of equipoise varied: although all were uncer-
tain about which trial treatment was optimal, they expressed different levels of uncertainty,
ranging from complete ambivalence to clear beliefs that one treatment was superior. Irre-
spective of their personal views, all clinicians intended to set their personal biases aside to
convey trial treatments neutrally to patients (in accordance with existing evidence). How-
ever, equipoise was omitted or compromised in 48/105 (46%) of the recorded appoint-
ments. Three commonly recurring practices compromised equipoise communication
across the RCTs, irrespective of clinical context. First, equipoise was overridden by clini-
cians offering treatment recommendations when patients appeared unsure how to proceed
or when they asked for the clinician’s expert advice. Second, clinicians contradicted equi-
poise by presenting imbalanced descriptions of trial treatments that conflicted with scientific
information stated in the RCT protocols. Third, equipoise was undermined by clinicians dis-
closing their personal opinions or predictions about trial outcomes, based on their intuition
and experience. These broad practices were particularly demonstrated by clinicians who
had indicated in interviews that they held less balanced views about trial treatments. A limi-
tation of the study was that clinicians volunteering to take part in the research might have
had a particular interest in improving their communication skills. However, the frequency of
occurrence of equipoise issues across the RCTs suggests that the findings are likely to be
reflective of clinical recruiters’ practices more widely.
Conclusions
Communicating equipoise is a challenging process that is easily disrupted. Clinicians’ per-
sonal views about trial treatments encroached on their ability to convey equipoise to
patients. Clinicians should be encouraged to reflect on personal biases and be mindful of
the common ways in which these can arise in their discussions with patients. Common pit-
falls that recurred irrespective of RCT context indicate opportunities for specific training in
communication skills that would be broadly applicable to a wide clinical audience.
Author Summary
Why Was This Study Done?
• Randomised controlled trials (RCTs) are a cornerstone of evidence-basedmedicine, but
they need to recruit sufficient numbers of patients if they are to provide answers to the
clinical questions they intend to address.
• Front-line clinicians are increasingly responsible for recruiting patients into RCTs, but
there are questions around how they reconcile their own views about RCT treatments
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with the requirement to convey “equipoise” to patients (the principle that the patient
would be neither advantaged nor disadvantaged if they were to receive any of the trial
treatments under investigation).
• Clinicians’ attempts to communicate equipoise have not yet been investigated in the
context of real doctor–patient interactions, and there are no evidence-basedrecommen-
dations for how clinicians should convey equipoise to patients who are eligible for RCT
participation.
What Did the Researchers Do and Find?
• We aimed to investigate how clinicians attempted to communicate equipoise to patients
across six RCTs, with the objectives of (i) identifying broad practices that support or hin-
der equipoise communication and (ii) examining how these practices compare with cli-
nicians’ intentions.
• We interviewedclinicians (n = 23) to understand their intentions for communicating
equipoise to patients, and audio-recorded their discussions (“appointments”) with RCT-
eligible patients (n = 105) to investigate their actual practices.
• Despite clinicians’ best intentions, equipoise communication was omitted or under-
mined in almost half of the appointments (n = 48) through commonly recurring prac-
tices that were apparent across the RCTs, including (i) offering treatment
recommendations, (ii) providing imbalanced descriptions of trial treatments, and (iii)
disclosing personal predictions about RCT outcomes.
What Do These Findings Mean?
• Communicating equipoise to patients is a delicate process that can be overridden or
undermined through commonly recurring practices that emerge irrespective of clinical
context.
• There are opportunities to create generic guidance for clinicians based on these common
challenges, with a view to facilitating the communication of equipoise to RCT-eligible
patients.
• Our findings were limited by our intentional focus on RCTs that were anticipated to
experience recruitment difficulties, and thus this issue needs further consideration in
RCTs that are deemed less challenging to recruit patients into.
Introduction
Optimising recruitment to randomised controlled trials (RCTs) is a priority for clinicians,
funding bodies, and healthcare decision-makers. Increasingly constrained resources reinforce
the need for efficient generation of high-quality evidence to optimise patient care and inform
service provision. Despite stringent review processes, at least half of funded RCTs fail to meet
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recruitment targets [1], and recruitment difficulties remain the most frequent reason for pre-
mature trial closure [2]. Not only are these difficulties associated with considerable financial
waste [3], but poor recruitment can delay progress or leave unanswered clinical questions in
underpowered or incomplete studies.
Attempts to unravel RCT recruitment difficultieshave focused on the pivotal role of front-
line clinicians as recruiters. Clinicians are on the interface of research and practice, and are
often responsible for presenting the option of RCT participation to eligible patients. Clinicians’
perceptions of “equipoise” has repeatedly been cited as an assumed barrier to RCT recruitment
[4,5]. Equipoise is broadly understood as a state of “substantial uncertainty” around treatment
superiority [6], though there are discordant views around the degree and nature of uncertainty
needed to justify randomisation [6]. Clinicians’ personal experiences and awareness of anec-
dotal or non-RCT evidence can disrupt their sense of equipoise. This has underpinned com-
mentaries on why recruiting to RCTs can be so challenging—particularly in disciplines that
have a propensity for swift and clear-cut decision-making (e.g., surgery) [7]. Equipoise at an
individual clinician level (“individual equipoise”) can thus be hard to achieve—especially
where ingrained clinical practices are under evaluation. The concept of “community equipoise”
(or “clinical equipoise”) refers to the principle that there is no consensus in the clinical commu-
nity about which treatment is best. In theory, this framing of equipoise enables clinicians to
align their instinct to act in the individual patient’s interest with the utilitarian endeavour of
benefiting future populations [8]. Although this viewpoint has been critiqued [9], clinical equi-
poise is widely accepted as the fundamental prerequisite that justifies an RCT. The pragmatic
definition of equipoise adopted in this study framed the concept as a state where patients
would be neither “advantaged nor disadvantaged” if they were to receive any of the trial treat-
ments (as far as existing evidencewould dictate) [10]. The recruiting clinician’s role was to con-
vey this notion to eligible patients.
Previous research suggests that patients’ reasons for declining trial participation are often
based on their interpretations of clinicians’ treatment preferences [11–14]; this raises questions
about how successfully equipoise is conveyed to patients in practice. Interview studies have
shown that clinical recruiters are not necessarily in individual equipoise [12,15–17] but assume
that their personal views can be set aside during encounters with trial-eligible patients [4,18].
Although there has been extensive theoretical commentary on these issues [5,19,20], equipoise
communication has not yet been investigated in practice. There is therefore little empirical evi-
dence to inform practical guidance for clinicians, despite recognition that discussing equipoise
is a core component of their roles. We set out to investigate how clinicians conveyed equipoise
during recruitment appointments in ongoing RCTs, with a view to identifying practices that
supported or hindered equipoise communication. A secondary objective of the study was to
examine how clinicians’ practices compared with their reported intentions.
Methods
Ethical approval for this study was granted by six UK research ethics committees, with full
details (e.g., dates, reference numbers) presented in S1 Text.
This was a qualitative study that adopted ethnographic approaches. Data were available
from three sources: (i) audio-recorded appointments in which clinicians presented RCTs to eli-
gible patients (“recruitment appointments”); (ii) interviewswith recruiting clinicians in which
perceptions of equipoise about trial treatments were explored, to enable comparison of
reported intentions and actual practices; and (iii) documentary analysis of trial protocols con-
taining the scientific evidence underlying the RCT, to aid interpretation of observedpractices
(e.g., assessing accuracy of information provision).
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Context and Data Sources
Data from 16 publicly fundedUK RCTs were available for inclusion, with an eventual sample
of six selected for the study (see below). The sampling frame of 16 RCTs spanned a range of
specialties (e.g., orthopaedics, vascularmedicine, oncology). All were set in UK National
Health Service–funded hospitals and had experienced (or were anticipated to experience)
recruitment challenges. Data collection and analysis for the present study were conducted by
the Qualitative Research Integrated within Trials (QuinteT) research team [21]. The lead of the
QuinteT team (J. L. D.) was a collaborator or co-applicant on the RCTs, contributing an
embeddedmethodological intervention that aimed to optimise recruitment: the QuinteT
Recruitment Intervention (QRI) [22]. Members of the research team had no direct involvement
in investigating the scientific questions the RCTs were addressing, but worked on the QRI. The
QRI comprised an in-depth investigation of the RCT’s recruitment processes and sources of
difficulty (Phase 1), followed by implementation of tailored strategies to address these chal-
lenges (Phase 2). Given this study’s focus on clinicians’ naturalistic practices, this paper draws
exclusively on data collected prior to any intervention (i.e., Phase 1).
More than half of the RCTs in the sampling frame included surgical interventions (10/16).
This reflected the team’s tendency to integrate the QRI into RCTs that were deemed “difficult”
for recruitment by the RCTs’ chief investigators and funding bodies. RCTs with surgical inter-
ventions are often thought to pose recruitment challenges due to cultural issues and assumed
difficulties in negotiating equipoise [7].
The QRI involved audio-recording recruitment appointments and interviewing recruiters to
understand recruitment processes. The methods employed for audio-recording appointments
and conducting interviewswere the same for each RCT, as summarised below.
Audio-Recording Appointments
Research nurses, local lead investigators, and central clinical trials units distributed informa-
tion sheets about the recording process to recruiters via email/in person and obtained written
consent for all of their recruitment appointments to be recorded (subject to patients’ permis-
sion). Research nurses and recruiters identified patients who were eligible to participate in each
RCT and distributed information sheets about the audio-recording process in person/via post.
Patients’ written consent was obtained in advance of the first appointment. Where prior con-
tact was not possible, verbal consent was sought to record the first appointment; this recording
was deleted if written consent was not subsequently provided. All appointments took place in
one of 16 National Health Service secondary care hospitals around the UK. Audio-recordings
were periodically transferred to the research team via encrypted data storage devices or secure
file transfer.
Interview Processes
Recruiters in each RCT were invited to take part in a semi-structured interview to establish
their individual perceptions of equipoise around the trial treatments. All recruiters in the
smaller-scale RCTs were invited to participate in this study. In larger multi-centre RCTs (e.g.,
with 20 centres or more), a purposefulmix of recruiters from centres that were recruiting well
and centres that were struggling to recruit were invited for interview. Research nurses, local
investigator leads, and central clinical trials units identified recruiting clinicians, distributed
information sheets via email/in person, and passed on consenting individuals’ contact details
to the interviewers (L. R., D. E., M. J., S. P., and C.W.). Although recruitment was also under-
taken by research nurses in some centres, the present study focused exclusively on clinical
recruiters in light of the study’s aims.
Clinicians’ Communication of Equipoise in RCTs
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A standard topic guide was used to ensure key issues were consistently covered in interviews
across the RCTs. This topic guide was modified as interviewsprogressed in each RCT to include
emerging recruitment issues that were specific to that trial. The broad topics of equipoise and
views about trial treatments were consistently covered across all interviews. Interviews took place
over the telephone or on hospital premises, involved just the researcher and clinician participant,
and were audio-recordedwith permission.Most interviewswere conducted prior to receipt of
the recruiter’s audio-recorded appointments, though there were a few cases where recording of
appointments had already begun at the time of interview. In these cases, the interviewersdid not
discuss any of their insights from listening to the appointments and recruiters had not received
any feedback or training on their practices based on the recordings. All participants provided
written informed consent. Field notes were used to record contextual details that might have
influenced interviewconduct and ideas for addition to topic guides.
Sampling Criteria for Cross-RCT Investigation
Sampling for the present investigation involved (i) selecting the RCTs and (ii) selecting the
audio-recorded appointments. A purposeful sample of four (of 16) RCTs was initially selected.
Sampling was directed by the intention to include a range of clinical specialties and types of
treatment comparison (e.g., trials comparing two or more existing treatments, trials comparing
current practice with a new technology).Although the sampling frame includedmore RCTs
with surgical interventions, we intentionally included two non-surgical RCTs to increase varia-
tion. Sampling was also partially informed by practical issues such as the number of audio-
recorded appointments collected. Two further RCTs were later added to the sample to con-
firm/disconfirmemerging findings. Details of the RCTs are shown in Table 1. The balance of
surgical to non-surgical RCTs in the final sample was reflective of the sampling frame.
Audio-recorded appointments from the six RCTs were eligible for inclusion if they took
place prior to any feedback to or training of the clinician (based on the recorded appoint-
ments), and if they were led by a clinician who had also been interviewed.
A total of 105 recruitment appointments met the study inclusion criteria and were analysed,
coupled with 23 interviewswith the clinicians who led these appointments. All clinicians were
secondary care consultants (surgeons, oncologists, and neurologists). Interviews lasted between
21 min and 92 min. The selected data collated for this study were collected betweenOctober
2010 and December 2014. None of the 23 clinicians or 105 patients withdrew from the study
(i.e., following provision of consent for the interviews or audio-recorded appointments).
The distribution of appointments per trial and clinician is shown in Table 1. In all, 83 of 105
appointments were with patients who ultimately declined trial participation (79%), 19 with
patients who agreed to randomisation (18%), and three with patients where the outcome was
not known (3%).
Analysis
Analysis was conducted after all the data had been collected from the individual RCTs and was
led by the corresponding author (L. R.), who had no involvement in the majority of the RCTs
included in the sample (5/6). As such, analysis was primarily conducted by an “independent”
researcher, who had no prior knowledge of links between the interviewswith clinicians and their
associated audio-recorded appointments. Analysis proceeded in three stages. First, analysis of
audio-recorded recruitment appointments focusedon how equipoise was conveyed in practice.
This occurred in conjunction with reviewing the RCT protocols to understand the nature of
equipoise underpinning each trial. Second, interview transcripts were analysed once initial analy-
sis of appointments was complete. This allowed themes emerging from the audio-recorded
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appointments to be generated as inductively as possible, without being influencedby knowledge
of clinicians’ views and perspectives.Third, findings from interviews and audio-recorded appoint-
ments were compared to examine how reported intentions correspondedwith actual practice.
Recruitment appointments were listened to in full, and any discussion about the trial and/or
trial treatments was transcribed verbatim if a full transcript of the appointment was not avail-
able. Full transcripts were available for four of the six RCTs, with two RCTs having “targeted
transcription”. Material that was not transcribed verbatim included discussion related to “rap-
port building”, appointment scheduling, aspects of history taking not relevant to the diagnosis
or trial, and technical descriptions of procedures that were often consistent across appoint-
ments for a particular recruiter. Transcripts were analysed using thematic techniques, guided
by constant comparison methods derived from grounded theorymethodology [29]. This
involved line by line coding and organisation of codes into themes as analysis progressed. A
coding frame was inductively developed, although there were a priori interests in examining
how equipoise was communicated. The broad definition of equipoise provided by Djulbegovic
et al. [10] informed coding. For example, any discussion/practices that supported the idea that
the patient would be neither advantaged nor disadvantaged if they were to receive any/either of
the trial treatments was coded as an example of conveying equipoise. Discussion/practices that
did not support the above idea were coded as practices that challenged equipoise communica-
tion. Analysis was iterative in that previously coded transcripts were revisited in light of new
codes/themes that emerged from later recordings. Analysis initially focused on RCT1, which
had yielded the largest number of recorded appointments provided by the largest number of
Table 1. RCT details and associated number of appointments recorded (shown by participating clinician).
RCT Number Used in This Study
(ISRCTN Reference)
Clinical
Specialty
Description of RCT Comparison Groups Clinician
Identifier
Number of Recorded
Appointments
RCT1 [23] (ISRCTN00786323) General
surgery
• Group 1: Surgical procedure 1
• Group 2: Surgical procedure 2
R1 19
R2 10
R3 16
R4 8
RCT2 [24] (ISRCTN98387754) Oncology • Group 1: Adjuvant treatment
• Group 2: Surveillance (with treatment offered on
signs of cancer recurrence, if appropriate)
R5 6
R6 2
R7 2
RCT3 [25] (ISRCTN42400492) Oncology • Group 1: Adjuvant treatment
• Group 2: Prognostic-test-directed adjuvant
treatment
R8 4
R9 7
R10 2
R11 1
RCT4 [26] (ISRCTN21144362) Vascular
medicine
• Group 1: Surgical treatment
• Group 2: Stenting
R12 4
R13 1
R14 1
R15 3
RCT5 [27] (ISRCTN33864128) Orthopaedics • Group 1: Arthroscopy with surgical manipulation
• Group 2: Arthroscopy alone
• Group 3: Active monitoring with specialist
reassessment
R16 3
R17 1
RCT6 [28] (ISRCTN89052791) Oncology/
surgery
• Group 1: Neoadjuvant treatment and surgery
• Group 1: Definitive non-surgical treatment
R18 5
R19 4
R20 2
R21 1
R22 1
R23 2
doi:10.1371/journal.pmed.1002147.t001
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recruiters. Appointments in three other RCTs were subsequently analysed to confirm, chal-
lenge, and develop themes from RCT1. This was followed by analysis of two further RCTs to
ensure saturation had been achieved. Saturation was defined as the point at which analysis of
appointments from three consecutive RCTs resulted in no new themes or lines of enquiry.
There was scope to continue sampling appointments from the 16 RCTs, but saturation was
achieved once 105 appointments had been analysed from six RCTs.
Data from audio-recorded appointments were summarised in a matrix displaying each
appointment (rows) against major themes from the final coding framework (columns). Rows
were grouped according to clinician and RCT to facilitate comparison at three levels: (i) across
a single clinician’s appointments to identify typical practices, (ii) between different clinicians of
the same RCT to identify within-trial patterns and variations, and (iii) across trials to identify
patterns and variations in practice across RCTs.
Interviewswere transcribed in full and analysed using constant comparison methods, as
described above. Data were organised and stored in NVivo (version 10, QSR International) to
facilitate analysis. Sections of transcript that related to issues of uncertainty, equipoise, and cli-
nicians’ views on the RCT treatments were coded in greater detail. Descriptive summaries of
each clinician’s account from interviewdata were arranged alongside summaries of their
observedpractices to allow comparison.
A number of quality control processes were employed to ensure rigour in the reported find-
ings. L. R. analysed all the data, with a subset of recordings from each trial double-coded by
two independentmembers of the research team (D. E. and J. W.). Coding of individual tran-
scripts was discussed in face-to-facemeetings. Differences in interpretation were resolved
through joint re-examination of original transcripts. Differences, where apparent, related to
subtle misunderstanding of an RCT’s context (an isolated example) and researchers’ inclina-
tions to occasionally code data in alignment with their particular research interests (which, on
discussion, were generally deemed out of remit for this study). Any other differences related to
individual researchers’ tendencies to code data at different levels (resulting in more or less
depth) and differences in terminology. In the latter case, discussion in meetings reassured that
this did not reflect different semantics. Findings were presented in teammeetings to ensure
these resonated with researchers who originally worked on the QRI integrated into each RCT.
There was a conscious effort to search for negative cases (examples that contradicted the broad
themes emerging from the data). These are reported in the findings, where relevant.
Results
Given the complex and novel approach to data collection and analysis of this study, the find-
ings have been presented in an order that most clearly conveys the key messages to emerge
from the study. A summary of clinicians’ individual perspectives on equipoise is presented
first, to provide a framework for drawing comparisons between reported intentions and actual
practices. The findings from the audio-recorded appointments—the focus of this study—are
presented next. References are made to clinicians’ interview accounts where relevant to demon-
strate how reported intentions compared with actual practices.
Interview Findings: Clinicians’ Individual Perceptions of Equipoise
Most clinicians expressed commitment to the RCT, acknowledging uncertainty amongst the
clinical community about how patients should be treated (community equipoise). All clinicians
acknowledged the need for evidence and indicated that they were individually “uncertain”
about optimal treatment. However, interview accounts revealed a spectrumof uncertainty,
ranging from complete ambivalence to strong beliefs about the superiority of a particular
Clinicians’ Communication of Equipoise in RCTs
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treatment. On the basis of the congruence of these findings with previous research [4], clini-
cians could be considered to fall on a continuum ranging from “clear equipoise” (equivocal
views about trial treatments) to “not in equipoise” (treatment preferences and/or unbalanced
views about trial treatments). All clinicians reported being uncertain or “in equipoise” on at
least one occasion during the interview, but approximately half presented treatment prefer-
ences or polarised views at other stages of the interview. Clinicians were therefore divided into
two groups: “more balanced” and “less balanced” (Fig 1). Those categorised as more balanced
(n = 10) consistently indicated that they viewed the trial treatments in equilibrium (Box 1).
Fig 1. Clinicians’ individual perceptions of equipoise, based on interview accounts.
doi:10.1371/journal.pmed.1002147.g001
Box 1. Interview Extracts Comparing More Balanced and Less
Balanced Clinicians’ Views on RCT Treatments
More Balanced Group
R5: Um, so in other words here equipoise, as I say I think I do have equipoise here
because I really do not know which is the best treatment for a patient. (R5, RCT2—more
balanced group)
R1: If I thought I knewwhat the answer was then I probably wouldn’t be interested in
being in the trial. (R1, RCT1—more balanced group)
R9: I don’t know what results this is going to be, I think there remains a degree of
uncertainty. It keeps me awake at night. (R9, RCT3—more balanced group)
Less Balanced Group
R7: [My] gut reaction is probably that it [treatment x] does something and something
needs to improve the outcome of these patients really, but my normal practice is not to
give [treatment x] because I have to do things that have got an evidence base. (R7,
RCT2—less balanced group)
R4: I think we’ll see what other trials have demonstrated. I think we’ll see that [treat-
ment x] is better initially. (R4, RCT1—less balanced group)
R2: I’m strugglingpersonally with what we’re going to do in the trial with the patients
who for whatever reason don’t get on with [treatment y]. (R2, RCT1—less balanced group)
Clinicians’ Communication of Equipoise in RCTs
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Less balanced clinicians (n = 13) expressed at least one clear preference or polarised opinion
about treatment superiority during their interview—either in a general sense or in relation to
particular sub-groups of eligible patients (Box 1). Evidence to support categorisation of each of
the 13 less balanced clinicians as such is presented in S1 Data.
Regardless of their individual perceptions of equipoise, all clinicians indicated that their aim
was to inform patients about the RCT without betraying their personal views. This reflected
these clinicians’ appreciation for community equipoise, which in turn reinforced prior work
conducted in this field [4]. Although some anticipated that they might inadvertently influence
patient choice, most believed they could achieve neutral information provision:
I can be unbiased during a presentation to them. [k] If you want me to be part of the ran-
domised trial then I can’t, I have to be completely non-biased. (R4, RCT1—less balanced
group)
I’m probably biased towards a surgical treatment slightly, but I try not to express that.
(R20, RCT6—less balanced group)
The less balanced versus more balanced categorisation provided a framework for comparing
clinicians’ individual perceptions of equipoise with their practices during recruitment
appointments.
Audio-Recorded Appointment Findings: Articulating Equipoise
Equipoise issues were discussed in most of the observed appointments (83 of 105, 79%).
Although the term “equipoise” was generally not used, the principle was described in a variety
of ways. Equipoise was most often discussed in collective (“we”) terms (79 of 83 [95%] appoint-
ments), thus indicating a tendency for clinicians to convey community (rather than individual)
equipoise during patient encounters. This included references to clinical communities not
knowing which treatment is best and presentations of equipoise as a global phenomenon
(“nobody knows which treatment is best”). Individual equipoise (“I don’t know which is best”)
was expressed in only 27 of 83 appointments (33%), though this was always in conjunction
with statements of collective equipoise.
Equipoise was most commonly portrayed through statements indicating an absence of
knowledge about which treatment was best (e.g., “we don’t know what’s best”) or through
explanations of what the RCT was seeking to achieve (e.g., “we’re trying to find out”). State-
ments specifyinguncertainty were also used, albeit less frequently (e.g., “we are uncertain”).
Equipoise was also occasionally communicated by emphasising treatment equivalence,most
often through reassurance that either/any trial treatment was equally appropriate for the
patient. These statements were not mutually exclusive, with most appointments incorporating
one or more of these statements (Table 2).
Audio-Recorded Appointment Findings: Difficulties Conveying Equipoise
Although equipoise was discussed in most appointments, over half of the clinicians (n = 16)
encountered difficulties in consistently conveying equipoise throughout their discussions with
patients. Most of these clinicians belonged to the less balanced group (n = 13), although there
were three more balanced clinicians who also encountered difficulties.
Three recurring practices obstructed or obfuscated communication of equipoise. These
practices varied in subtlety and were identified across multiple RCTs, irrespective of context.
The patterns were: (i) overriding equipoise (e.g., by recommending a treatment), (ii) under-
mining equipoise (e.g., by communicating a preference), and (iii) omitting equipoise (e.g.,
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avoiding presenting or discussing equipoise). Each of these is presented in more detail below.
Overall, 48 of the 105 appointments (46%) demonstrated one or more of these difficulties.
Overriding equipoise. Equipoise was overridden in nine appointments by clinicians
clearly recommending a treatment option. Five clinicians from five RCTs recommended treat-
ments in at least one of their appointments with trial-eligible patients. Most of these recruiters
(n = 4) had revealed discomfort with one or more of the trial treatments in their interviews.
This discomfort was apparent in appointments when patients appeared unsure or ambivalent
towards treatment options, or had particular characteristics that challenged that particular cli-
nician’s sense of equipoise. For example, R4 (RCT1; Box 2) had expressed in the interview a
preference for patients to receive particular trial treatments on the basis of their age, but also
expressed the intention to refrain from conveying these biases to patients. Despite this, the
recruiter went on to provide treatment recommendations to a number of patients, justifying
their advice on the basis of these characteristics. Similarly, R8 (RCT3; Box 2) had intended to
convey equipoise to the full range of eligible patients, yet reverted to recommending a particu-
lar treatment when faced with patients whose clinical characteristics placed them near the lim-
its of the trial’s eligibility criteria (for the patient in R8’s extract in Box 2, the estimated level of
benefit of treatment x placed the patient within the trial’s eligibility criteria; this RCT’s justifica-
tion was built on the premise that there is uncertainty around the eligible patient group’s
potential to benefit from treatment x).
Undermining equipoise: imbalances in treatment presentation, and disclosure of opin-
ion. Another pattern of communication that was problematic was the more subtle undermin-
ing of equipoise. This was apparent through imbalanced descriptions of trial treatments, and
disclosure of clinicians’ opinions and predictions about RCT findings. Fourteen clinicians
(from all six RCTs) demonstrated at least one of these patterns. All bar one of these clinicians
belonged to the less balanced group, based on the views they had expressed in interviews.
Equipoise could be undermined by implying that one trial treatment was more established
than another. This was particularly problematic in RCTs evaluating treatments that were
already used in routine practice. The treatments in these RCTs were particularly prone to clini-
cal practice variations based on clinician preference. Some recruiters used loaded descriptors
such as “gold standard” or “global standard” in relation to one trial treatment, without further
explanation that the comparator may be just as good or better. These practices contrasted with
other recruiters (from the same RCTs) who introduced the treatments in more neutral terms
Table 2. Clinicians’ descriptions of the concept of equipoise to patients during RCT recruitment appointments.
Type of Statement Examples Appointments
That Included at
Least One
Example of the
Statement Type,
n = 83
Number Percent
Intentions of RCT: specification of what the
RCT is seeking to achieve
“We’re trying to find the answer”; “we have a study that’s looking at comparing
[treatment x] and [treatment y] to see which is better”
64 77%
Absence of knowledge: specification of not
knowing
“We don’t know what’s best”; “I would love to know which is better” 61 74%
Limitations or absence of evidence “There is not enough evidence to say” 28 34%
Uncertainty: statements that allude to not being
sure or certain
“We do these studies when there is uncertainty”; “I can’t say for sure which is best” 27 33%
Emphasising patient suitability for both/all
treatments
“My assessment of you is that you would be suitable for either treatment” 22 27%
doi:10.1371/journal.pmed.1002147.t002
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(e.g., by discussing practice variations or emphasising current assumptions that both/all trial
treatments were equivalent).Within-trial variations in different recruiters’ descriptions of trial
treatments are illustrated in Box 3. One of these quotes is from a more balanced clinician con-
sidered to be an outlier (R5), in that he/she did not follow the same pattern observed
Box 2. Extracts Comparing Clinicians’ Views/Intentions for Communicat-
ing Equipoise as Reported in Interviews with their Practices of Providing
Treatment Recommendations in Audio-Recorded Recruitment
Appointments
R4, RCT1—Less Balanced Group
Clinician’s views/intentions expressed in interview:
R4: Hmm, I have to say, I mean being honest, with the more elderly patients with
more co-morbidities, diabetes, I tend to go straight for [procedure x] on those patients
(in routine practice). Hmm, just because they’ve got a limited life expectancy. In the
younger patients I get with the less co-morbidities, I certainly have a preference for [pro-
cedure y].
R4: I think you present it fairly and then leave it up to the patient to make their own
mind up. [k] I can’t then guide them into which one I think they should have.
Communication in practice:
R4 [at outset of appointment]: Have you thought about what sort of [treatment] you
want?
Patient: Yes. [Patient explains preference for treatment x]
R4: Ok. I’m going to talk to you about that, because of your age. I’m going to have a
chat with youk and the way you [explains characteristic]. I might try to steer you in a dif-
ferent direction I’m afraid. [k] I’ll explain that a little bit more. Let me go through the
optionsk. I mean, once you’ve heard all the options, I’m going to ask you the same ques-
tion and we’ll have a chat about it. [Recruiter explains treatment options]
R4: And that’s why I was going to ask you what do you think you should have done.
Because with your age and [characteristic], you would do well with [treatment y]. [k] My
feeling would be for [treatment y], um—because you’re otherwise relatively fit. The only
real illness you have is [names illness]. I’m just wary of putting someone so young
through [treatment x].
R8, RCT3—Less Balanced Group
Clinician’s views/intentions expressed in interview:
R8: Then you start talking about the numbers and then at the end of the consultation
you say, “Actually you can see the benefit from [treatment x] isn’t great, so normally this
is a decision which is made by the patient and the doctor together.”
Communication in practice:
R8: [So I think] I mean if you think about it in a stepwise way, leaving the trial to one
side, do you think that level of benefit is enough to warrant [treatment x]?
Patient: Yes.
R8: Yes [overlaps]. And I would sayk certainly your doctors would agree with you,
and most patients would agree with you. So I think, the initial question is, should we pro-
ceed with [treatment x]k the answer is “yes”.
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throughout this study. Whilst most of the more balanced clinicians did not demonstrate any of
the difficulties in equipoise communication encountered by the less balanced clinicians, R5
was an exception. Despite being categorised as more balanced on the basis of the interview, this
clinician went on to undermine equipoise in practice.
Treatment superiority was also implicitly communicated in some clinicians’ descriptions of
the research question. For example, some clinicians from RCT1 and RCT6 presented the trial
as an investigation of whether treatment x was “as good as” treatment y (R4 and R20; Box 4).
Both treatments from these RCTs were widely used (albeit variably) in routine practice. These
statements and hypotheses did not reflect the information and evidence presented in the RCT
protocols. Furthermore, these loaded descriptions were in stark contrast to more neutral
descriptions of the treatments/RCT rationale provided by other clinicians recruiting to the
same RCTs (e.g., R1 and R21; Box 4).
Box 3. Communication in Practice: Extracts from Audio-Recorded
Appointments Illustrating Clinicians’ Variable Descriptions of Treatments
Available in Routine Practice
R7: People historically have either done very close follow-up, because they’ve said,
well look there’s no evidence to give [treatment x]. Or they’ve done [treatment x] because
they said there’s no evidence not to give [treatment x]. (R7, RCT2—more balanced
group)
R5: Well [k] let me tell you what [k] I think the global standard of care is. I think that,
umk so nobody’s saying we would never give you [treatment x]. But we would not nor-
mally give [treatment x] at this point. (R5, RCT2—more balanced group; outlier)
R20: We’ve been very keen to try and compare the two treatments—certainly [treat-
ment x] has always been held up as the gold standard, which is fair enough. (R20, RCT6
—less balanced group)
R23: The difficulty is that there [k] isn’t a right and a wrong way of treating it. There
are two very different treatments available for it and at the moment we don’t really know
whether one is better than another. (R23, RCT6—more balanced group)
Box 4: Communication in Practice: Extracts from Audio-Recorded
Appointments Demonstrating Within-RCT Variation in Recruiters’
Descriptions of Trial Treatments
R4: Part of this trial is to establish whether if the follow up for [treatment y] is good, is
it as good as [treatment x]. (R4, RCT1—less balanced group)
R1: We don’t know if one [treatment] is better than the other or if they are just alter-
natives. (R1, RCT1—more balanced group)
R20: Whether [treatment x] has got a tiny benefit over the [treatment y] we don’t
know, that’s what we are trying to find out. (R20, RCT6—less balanced group)
R21: Now, there is evidence—or the—people think there is reasonable evidence that
both treatments have similar outcomes but we don’t know that for sure. There’s not been
a trial to show if one treatment is better at curing you than another treatment. (R21,
RCT6—more balanced group)
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Patients’ responses provided insight into how recruiters’ descriptions of trial treatments
could be interpreted (Box 5). Use of terms such as “gold-standard” and statements about one
treatment being potentially “as good as” another were not supported by information stated in
the RCT protocols. These descriptors had a clear influence on patients’ interpretations of treat-
ment safety and likelihoodof effectiveness (Box 5, extracts 1–3). Some terms could be consid-
ered “loaded” based on the clinical context in which they were mentioned. For example, some
descriptions of tumour removal in RCT6 implied greater assurance of therapeutic benefit with
one procedure over the other (Box 5, extract 4).
Box 5. Communication in Practice: Extracts from Audio-Recorded
Appointments Illustrating Patients’ Interpretations of Imbalanced Treat-
ment Presentations
Extract 1: R18, RCT6—Less Balanced Group
R18: And there have been some very good results when we do [treatment x], but
they’ve never ever been compared with what has been, over many years, the gold stan-
dard treatment [which is treatment y].
Patient [later]: Right. Well, if I went into the study and obviously was offered [treat-
ment y], and it didn’t work?
Extract 2: R22, RCT6—Less Balanced Group
R22: One is—it’s a traditional treatment which is practisedmostly around the world
—or the world most commonly—and also more traditionally is (treatment x).
Patient partner [later]: This has all coming about because of the new technology
[treatment y] or whatever. I mean, if you’re talking thirty, forty years ago, automatically
you’d have had [treatment x].
Patient partner [later]: But I’d just say Ik do we want to try the new technology, or
stick with the old technology?
Extract 3: R4, RCT1—Less Balanced Group
R4 [after describing definite beneficial effects of treatment x]: However, if you use
[treatment y], well, potentially you can get the health benefits that you want, but it does
require a lot of input from you.
Patient: Looking at what you told us, [treatment x] would be the best option for me,
because it’s a quick answer to my health problems.
Extract 4: R18, RCT6—Less Balanced Group
R18: The first is [treatment x] to remove the cancer to give us the chance of cure.
R18 [later]: [Treatment y] is designed to shrink down the tumour and try and kill it
off.
Patient relative: The thing that’s worryingme if she has [treatment y]k if that doesn’t
take it awayk but if she has [treatment x] then it’s gone.
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Equipoise was also underminedby clinicians predicting RCT findings. This was demonstrated
by half of the clinicians observed,mostly in the less balanced group. Some clinicians tempered
their predictions about trial outcomes with uncertainty and reiteration of the trial aims:
R7: That’s because I don’t know whether giving [treatment x] now is any better than just
closely following you up. My gut reaction is that it may be, but I can’t prove, until we finish
off this study. (R7, RCT2—less balanced group)
There were, however, also examples of clinicians expressing their predictions and opinions
without reiterating uncertainty:
R5: We would be reluctant to recommend [treatment x] in the absence of evidence because
I think if there is a benefit from [treatment x] it will be small. (R5, RCT2—more balanced
group; outlier)
Four of the RCTs included examples of clinicians not fully and accurately communicating
equipoise as it was conveyed in the RCT protocols. Examples of practices that jeopardised equi-
poise communication included presenting non-evidence-basedinformation with certainty and
showing confidence in the likely outcome of the RCT. The extracts below compare two clini-
cians’ approaches to introducing equipoise in an RCT that compared two surgical interven-
tions with conservative therapy (RCT5). The first clinician (R16) articulates the three-way
uncertainty as per the trial protocol, whereas the second (R17) implies a degree of certainty
that one treatment (surgery) works. Equipoise as communicated by R17 thus appeared to be
about “how”, rather than “whether”, surgery was effective:
R16: The trouble for us at the moment is we don’t know whether to be offering people
this operation. [k] And, if it is to work, we don’t know quite how it works. (R16, RCT5—less
balanced group)
R17: How that surgery works is not at all clear. What we’re doing at the moment is par-
ticipating in a trial. The idea is that that should hopefully give us some information as to
which of those forms of treatment is producing the improvement in the people who do get
better. (R17, RCT5—less balanced group)
Over-expressing confidence in a particular trial arm without reiterating uncertainty was par-
ticularly evident in RCTs that compared current practice with novel approaches. Comparison of
clinicians’ communication in practice (in appointments) with their expressed views/intentions
(in interviews) revealed that tendencies to present opinions as facts were likely to be unwitting:
R10 [in interview]: So I say [to patients] because we don’t know that [novel technology]
is useful, the way the trial works is that half the people will just getk [goes on to explain ran-
domisation]. (R10, RCT3—less balanced group)
R10 [in appointment]: I have no concerns that it’s a dodgy [technology] or anything. I
think it’ll give us a good result. (R10, RCT3—less balanced group)
Omitting equipoise. Discussion of equipoise was omitted in 22 appointments, from five
of the six RCTs. Some of these omissions were associated with the issues discussed above (e.g.,
clinician-initiated treatment recommendations). The remainder were characterised by particu-
lar patterns in the ways clinicians structured or led the discussion: clinicians leading these
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appointments directly elicited patients’ preferences and accepted these without exploration, or
geared the appointments towards patients selecting a treatment. These patterns were demon-
strated by clinicians from both the less balanced (n = 3) and more balanced (n = 2) groups, and
thus occurred irrespective of clinicians’ individual perceptions of equipoise. Some of these cli-
nicians had, however, expressed particular areas of discomfort in their interviews: namely, dif-
ficulties around transitioning from routine practice to recruitment appointments (Box 6, R18
and R2) and concerns about how to deal with patient preferences without appearing coercive
(Box 6, R22).
Discussion
This study investigated how clinicians communicated equipoise in RCT recruitment appoint-
ments. Presenting and sustaining equipoise was found to be a challenging process that was
highly entwined with clinicians’ own perceptions of equipoise. Clinicians varied in terms of
their individual sense of equipoise, but were committed to the RCTs and reported that they
intended to present treatments to patients in a neutral and balancedway. These expressed
intentions did not always translate into practice—especiallywhen clinicians harboured individ-
ual preferences or polarised views about treatments. Although equipoise was articulated in
most appointments, observations across the RCTs revealed common practices that compro-
mised equipoise communication. Clinicians with treatment preferences or less balanced views
overrode or undermined equipoise through offering treatment recommendations, presenting
imbalanced descriptions of trial treatments, or making clear their predictions about trial out-
comes. These difficulties arose despite clinicians’ intentions to conceal or suspend their per-
sonal inclinations or beliefs.
A key strength of this study was its analysis of real (rather than reported) practices and
events. Issues of recollection bias and selective reporting were thus minimised. Paired interview
and observational data allowed novel comparison of intended and actual practices, providing
Box 6. Interview Extracts Providing Insights into Why Clinicians Omit
Equipoise
R18: If you think about it we’re often expecting patients to get involved in decision-
making, and in other situations outside of randomised studies we might say to the
patient, “Look, there’s treatment A or there’s treatment B—which would you prefer?”,
and then we’re expecting patients to decide. (R18, RCT6—less balanced group)
R2 [in reference to routine practice]: [When patients are] very clear about why they
want to have an operation, or which operation they want to have, then I used to heave a
sigh of relief because I thought, “Great, this patient is on board, they are clearly engaged.”
[k] So the problem of course now is that we have a situation whereby people are coming
to us and we want them to say, “I was rather hoping you’d tell me the difference between
the operations so that you can help me make my mind up,” because then you can say
exactly “Actually wonderful, [k] we don’t know which is the best operation.” [k] So of
course we actually have to, in a sense, undo what we’ve done. (R2, RCT1—less balanced
group)
R22: If you won’t accept a patient’s choice then you’ve probablyk you’re in the
grounds of coercion. (R22, RCT6—less balanced group)
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potential explanations for some of the observedpractices. The study drew on a large dataset
derived from a range of RCTs and clinical contexts, and focused on common practices that
were identified across these settings. As such, findings were not limited to a particular RCT
context and are likely to be applicable more widely. A qualitative approach was crucial for this
particular research question given the absence of prior empirical research and the need for an
inductive approach. We made a conscious effort to look across a broad range of RCTs and
focus on the practices that were common across these contexts. The reported findings are thus
likely to be salient to clinicians across specialties.
The study had a number of limitations. Data were derived from RCTs that were experienc-
ing (or were anticipated to encounter) recruitment difficulties.There was a prior intention to
focus on challenging RCTs with a view to informing strategies to overcome recruitment diffi-
culties, but our findings need to be considered further in RCTs that recruit well. Another limi-
tation was the reliance on RCTs involving surgical interventions, which could have raised
particular issues. Nonetheless, our sample also included RCTs that did not include surgical
interventions, and although these were fewer in number, we did not identify any notable differ-
ences between RCT types in relation to the key findings. Integration of the recruitment sub-
study (QRI) across multiple RCTs meant that some processes (e.g., study invite distribution)
were organised centrally (e.g., by clinical trials units) or influenced by local issues (e.g., research
nurses’ capacity and work patterns in RCT centres). We did not have a sense of how many
patients and clinicians declined participation in our study (or were not approached), and as a
consequence it is possible that the data captured provide insights from particular groups of
patients/clinicians.We believe this is unlikely in the case of patients, as informal discussion
with research nurses revealed that it was rare for patients to decline consent for audio-record-
ing their appointments. If recordings were not captured, this tended to be due to logistical or
organisation issues. However, findingsmay be limited by the self-selected clinicians who agreed
to be interviewedand to have their appointments audio-recorded. As these individuals may
have been particularly interested in improving communication or supportive of the RCT, it
might be that problematic presentations of equipoise are more pronounced in appointments
led by clinicians whomight not have been as engaged with the research. The audio-recording
process itself may have altered clinicians’ practices, though, again, any Hawthorne effect is
likely to have manifested as recruiters beingmore mindful of concealing their views. Some of
the clinicians participating in the study contributed only one appointment for observation,
which limited the scope to compare clinicians’ reported and actual practices. The limitations
relating to the lack of information about clinicians/patients who did not volunteer/agree to par-
ticipate, and the potential influence of the Hawthorne effect, are partly countered by the fact
that we identified similar challenges across clinicians/RCTs. This lends some assurance to the
integrity of the key findings presented. Finally, like any interview-basedstudy, it is possible
that participants’ accounts were influenced by their knowledge of the researchers’ interests (in
this case, recruitment). Clinicians were nonetheless not aware of our specific interest in investi-
gating equipoise.
Much of the literature around clinical equipoise has been theoretical, although there have
been some empirical studies that have focused on clinicians’ reported difficultieswith negotiat-
ing equipoise. These studies indicate that clinicians often assume that personal struggleswith
equipoise can be set aside during patient encounters and have no bearing on recruitment
[4,18]. However, studies reporting patient perspectives indicate that their decisions around
trial participation can be guided by their interpretations of what their clinician prefers or rec-
ommends [11–14]. There is also evidence to suggest that patients construct these interpreta-
tions based on perceived cues, rather than direct statements [14]. The present study bridges
these bodies of evidence by providing insight into what actually happened during particular
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RCT recruitment appointments. This has enabled a detailed examination of how equipoise is
put into practice, and identification of commonly recurringways in which equipoise commu-
nication can be compromised.
Some of our findings are supported by previous research involving observations of recruit-
ment appointments. These studies were largely nested in single RCTs and reported on trial-
specific challenges clinicians encountered. For example, the potential for loaded terminology to
disrupt equipoise has been reported in RCTs of laryngeal and prostate cancer [30,31]. The
scope to look across RCTs helped us to distinguish particular aspects of discussions that are
prone to loaded terminology or misrepresentation, such as portrayal of current practice and
descriptions of the RCT question [30]. These areas could be amenable to generic training or
guidance that encourages clinicians to carefully articulate the information specified in the trial
protocol.
Though there are fewmulti-RCT studies of communication practices, one study by Jenkins
and colleagues included a content analysis of how frequently particular trial concepts were
mentioned in recruitment appointments [32]. Although “equipoise” was not specifically con-
sidered, the authors reported that “uncertainty” was mentioned in almost all of the 82 appoint-
ments observed.By contrast, we found equipoise discussionwas omitted in 20% of the
observed appointments. This discrepancymay be explained by differences in sample sizes and
clinical contexts. Jenkins and colleagues observed fewer clinicians’ practices (n = 5) and focused
solely on oncology trials. Oncologists are more accustomed to discussing issues of equipoise
and uncertainty, compared to clinicians working in other specialties, such as surgery [7]. The
greater diversity of clinical specialties and greater number of clinicians observed (n = 23) in our
study may explain the comparatively higher proportion of recruitment appointments that
omitted discussion of equipoise/uncertainty. Other studies have also shown that equipoise is
often omitted from RCT recruitment discussions, though these studies also specificallymea-
sured the frequency of statements of “uncertainty” [33,34]. Reported presentations of equipoise
in this study were based on clinicians’ own terms, rather than preconceived assumptions. This
confirmed that statements of equipoise often extend beyondmere mention of uncertainty, as
suggested in prior descriptions of how clinicians discuss equipoise in interviews [35].
Introducing the concept of equipoise to patients can be a challenge in its own right, as indi-
cated by our findings that some clinicians were inclined to omit the concept from recruitment
appointments. The substantial literature on clinicians’ management of medical uncertainty
may be particularly helpful for illuminating explanations for the omission of equipoise. Uncer-
tainty is a complex, multifaceted phenomenon that is pervasive throughout the medical litera-
ture. The definition of equipoise used in this study most closely aligns with the notion of
scientific ambiguity—uncertainty in clinical recommendations on the basis of insufficient sci-
entific evidence [36]. There has been remarkably little research that investigates how scientific
ambiguity is operationalised in routine practice, although the small body of evidence that does
exist has highlighted two broad strategies adopted by clinicians: creating an illusion of certainty
[37–39] and transferring uncertainty to others (such as the patient) [37,38,40,41]. Our observa-
tions of clinician-initiated recommendations and tendencies to gear appointments towards
patients choosing a treatment may therefore reflect strategies used to address uncertainty in
routine practice, and underlie why recruitment needs to be recognised as a different activity
[42]. There are opportunities for future research to compare recruitment appointments with
routine consultations to explore issues arising from these different contexts.
The concept of equipoise is poorly demarcated in the literature, and, as such, the findings of
this study need to be interpreted in light of the assumptions we have made and the stances we
have taken. Equipoise can be considered in two contexts: first, as a phenomenon that justifies
an RCT proposal and, second, as a rationale for randomisation presented during an RCT
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recruitment appointment. This study assumed that public funding of the RCTs indicated there
was sufficient justification for the RCTs, although questions have also been raised around
whether equipoise should take account of considerations such as social values and cost of treat-
ment [43]. Definitions of equipoise in the context of the RCT recruitment appointment can
also vary. Rather than an inductive grounded theory investigation [29], we specified a priori a
broad and pragmatic definition of equipoise as a state where a patient would be neither advan-
taged nor disadvantaged if they were to receive any of the RCT treatments under investigation,
based on existing evidence.We assumed that a patient who is clinically eligible for an approved
RCT should be equipped with evidence-based information that ensures they are aware that the
interventions under consideration would be safe, equivalent, and appropriate for them. This
does not, however, account for external or patient-related non-clinical factors that can alter
this balance. Future research needs to examine how patients’ values, beliefs, and preferences
are managed in the RCT recruitment appointment, and the implications this has for recruit-
ment outcomes. Focusing on recruiters’ explanations and information provision in isolation
risks creating an oversimplified picture of what is likely to be a complex set of interactions. Our
findingsmay also have oversimplified some issues through our pragmatic labelling of clinicians
as more or less balanced. This labelling acted as a proxy for individual equipoise but does not
take account of the continuum of views we identified.Our findings should thus be viewed as an
initial step, in need of future refinement.
The findings of this study have practical implications. Identification of commonly recurring
communication challenges provides opportunities for targeted strategies to improve practice.
The practices that obfuscated equipoise communication varied in nature and would require
different solutions. Treatment recommendations were the most extreme practices that contra-
dicted equipoise. Recommendations were often rationalised in terms of patients’ characteris-
tics, presented by clinicians who had alluded to being uncomfortable with particular aspects of
trial eligibility criteria. Previous research has also shown that clinicians’ perceptions of equipoise
can waver at the limits of eligibility criteria [4]. Like any aspect of clinical practice, patients’ suit-
ability for trial interventions needs to take into account individual patient circumstances. How-
ever, difficulties arise when patients are steered against RCT participation on the basis of clinical
or biological characteristics that are not stated as formal exclusion criteria. Filtering patients on
these bases can have implications for the generalisability of RCT findings and interfere with eligi-
ble patients’ autonomy to make decisions about trial participation.One solution to untangling
these difficultiesmight be to promote open discussion about discomfort or concerns about trial
eligibility criteria during trial initiationmeetings and site visits [4,42]. The QRI uses evidence
from audio-recorded appointments and interviews to air these issues during investigator feed-
back and training sessions [22]. Recording detailed reasons for patients not entering a trial (e.g.,
in screening logs) will also lend some transparency to trial conduct. These reported details will
need to go beyond ambiguous statements such as “clinician discretion”. Another alternative is for
nurses or other professionals to undertake recruitment.While nurses do increasingly take on this
responsibility, clinicians need to be accustomed to presenting equipoise and uncertainty comfort-
ably: patients will still look to clinicians for advice, irrespective of whether clinicians are actively
recruiting into an RCT. Furthermore, there is encouraging emerging evidence that it is possible
for clinicians to learn recruitment skills [22,44,45].
This study found that clinicians often shared their opinions and predictions about RCT out-
comes with patients. This raises questions around what should be expected of clinicians who
hold the dual roles of physician and RCT recruiter. Avoiding personal viewsmay be difficult in
situations where patients request an opinion or recommendation. Trials that involve treat-
ments that differ to usual care pose particular challenges, as clinicians need to have a degree of
faith in “the new” to justify disrupting usual practice. Conversely, clinicians may also need to
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justify use of older, less innovative treatments in trials that evaluate novel interventions that
have already diffused into routine practice without a supporting evidence base. Consistently
communicating the concept of community equipoise throughout the appointment is one
potential solution to responding to recommendation requests. The principles underpinning
Chard and Lilford’s distinction between absolute equipoise and effective equipoisemay also be
useful here, in which equipoise around a single outcome (absolute equipoise) is distinguished
from equipoise created by balancingmultiple considerations (e.g., financial costs, side effects,
effectiveness, quality of life) (effective equipoise) [5]. This alternative approach to viewing equi-
poise may provide a helpful framework in practice for balancing the advantages and disadvan-
tages of trial treatments in efforts to sustain equipoise.
The common occurrence of particular equipoise-related difficulties across trials suggests
that these challenges are amenable to generic training that could be incorporated into under-
graduate and postgraduatemedical curricula—particularlygiven that clinicians are increas-
ingly expected to discuss issues of uncertainty and evidence. Recommendations for improving
communication may also be adopted if clinicians are able to consider and apply these in the
context of an RCT they are working within. A current programme of applied research has been
developed to address recruitment difficulties by delivering tailored interventions as RCTs pro-
ceed [22]. Interventions applied within RCTs to date have included training around some of
the issues reported in the present study [45]. Our findings also raise the possibility of targeting
training to recruiters based on their individual perceptions of equipoise expressed at the trial’s
outset (e.g., through interviews). Further research will need to investigate whether training can
lead to sustained change in the practices of less balanced clinicians.
This study did not intend to make causal inferences between recruiters’ practices and trial
participation outcomes, though there is potential for future research to examine possible asso-
ciations. There is also potential to consider how categorisation of recruiters as more or less bal-
anced is associated with recruitment outcomes, although this would run counter to our
interpretation of individual equipoise falling on a continuum. Such efforts will need to consider
the complex nature of patient decision-making,which can be influenced by an array of factors
within and outside the recruitment appointment. Future research may also consider patients’
interpretations of appointment events—particularly their perspectives on equipoise and trial
participation immediately following appointments, and levels of informed consent.
Conclusion
Communicating equipoise in practice is a delicate process that can be challenging, especially
when clinicians are negotiating their own struggleswith equipoise. Despite clinicians’ assump-
tions that personal biases and preferences can be set aside, these can unwittingly materialise in
encounters with patients. This phenomenon calls for careful reflection and training to enable
clinicians to communicate equipoise as they intend. Guidelines may need to consider the possi-
bility of offering training based on clinicians’ conveyed (rather than intended) perceptions of
equipoise.
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